# FDA recall D-0996-2019

> **Lannett Company Inc.** · Class III · drug recall initiated 2019-02-21.

## Product

Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154  NDC: 62175-271-37

## Reason for recall

Failed Dissolution Specifications

## Distribution

Nationwide, including Puerto Rico.

## Key facts

- **Recall number:** D-0996-2019
- **Recalling firm:** Lannett Company Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-02-21
- **Report date:** 2019-03-20
- **Termination date:** 2020-11-06

- **Voluntary/Mandated:** N/A
- **Location:** Seymour, IN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0996-2019

## Citation

> AI Analytics. FDA recall D-0996-2019. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0996-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*